AtriCure (ATRC) Payables (2010 - 2026)

AtriCure (ATRC) has 17 years of Payables data on file, last reported at $30.6 million in Q1 2026.

• On a quarterly basis, Payables rose 21.38% year-over-year to $30.6 million in Q1 2026; TTM through Mar 2026 was $30.6 million, a 21.38% increase from a year earlier, with the FY2025 full-year figure at $25.3 million, up 1.11% from the prior year.
• Payables for Q1 2026 stood at $30.6 million, up from $25.3 million in the prior quarter.
• Over the last five years, Payables for ATRC reached as high as $31.7 million in Q3 2024 and fell as low as $19.9 million in Q4 2022.
• Historically, Payables has averaged $25.4 million across 5 years, with a median of $25.2 million in 2025.
• Across the five-year window, Payables jumped 43.8% in 2022 and decreased 19.74% in 2025, its largest moves.
• Year by year, Payables stood at $19.9 million in 2022, then jumped by 37.47% to $27.4 million in 2023, then dropped by 8.49% to $25.0 million in 2024, then rose by 1.11% to $25.3 million in 2025, then increased by 20.73% to $30.6 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $30.6 million in Q1 2026, $25.3 million in Q4 2025, and $25.5 million in Q3 2025.